Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of Duchenne muscular dystrophy with myoblasts expressing dystrophin and treated to block myostatin signaling

Treatment of Duchenne muscular dystrophy with myoblasts expressing dystrophin and treated to block myostatin signaling

US Patent 7887793 · Granted Feb 15, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CRISPR-based methods and products for increasing frataxin levels and uses thereo2019
Reduction of amyloid beta peptide production via modification of the APP gene us2019
Methods and products for increasing frataxin levels and uses thereof2017
Culture medium for myoblasts, precursors thereof and derivatives thereof2015
Myogenic differentiation of stem cells and uses thereof2014
Meganuclease reagents of uses thereof for treating genetic diseases caused by fr2014
Method of in vitro preconditioning healthy donor's myoblasts before transplantat2007
Treatment of hereditary diseases with gentamicin2002
Method of in vitro preconditioning healthy donor's myoblasts before transplantat1998